Regulus Therapeutics Inc is a biotechnology company focused on the development of microRNA therapies.
Ratings
0 / 5
0 ratings in the last 12 months
5
4
3
2
1
CEO
Mr. Joseph P. Hagan$145.3M
Market Cap • 24/04/20242009
(há 15 anos)
2012
(12 years ago)
NASDAQ
Listagem
San Diego
Sede • California30
N° de Empregados • 2022Valuation
Company FinancialsValuation Indicators
Valuation IndicatorsRetorno Histórico
RGLSSó no Premium...
Visualize o retorno de longo prazo das ações. Dividendos e outros eventos são considerados.